(Q44052345)

29 November 2017

Can combined androgen blockade provide long-term control or possible cure of localized prostate cancer? (English)

1 reference

29 November 2017

1 reference

Fernand Labrie

1

1 reference

29 November 2017

Bernard Candas

series ordinal

2

1 reference

29 November 2017

Jose-Luis Gomez

series ordinal

3

1 reference

29 November 2017

Leonello Cusan

series ordinal

4

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

60

1 reference

29 November 2017

1

1 reference

29 November 2017

115-119

1 reference

Prostate cancer consensus hampered by lack of data

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901639-4

7 January 2021

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901639-4

7 January 2021

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901639-4

7 January 2021

Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901639-4

7 January 2021

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901639-4

7 January 2021

Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901639-4

7 January 2021

Maximum androgen blockade in advanced prostate cancer: a meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901639-4

7 January 2021

Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901639-4

7 January 2021

Maximum androgen-blockade with medical or surgical castration in advanced prostate cancer: A meta-analysis of nine published randomized controlled trials and 4128 patients using flutamide.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901639-4

7 January 2021

Combination therapy with flutamide and the LHRH agonist [D-Trp6, des-Gly-NH(2)10]LHRH ethylamide in stage C prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901639-4

7 January 2021

Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901639-4

7 January 2021

Unique features of the basal cells of human prostate epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901639-4

7 January 2021

10.1016/S0090-4295(02)01639-4

Identifiers

DOI

1 reference

release_npbhqpunjbhlnnefx2itsuv6iy

29 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/npbhqpunjbhlnnefx2itsuv6iy

24 November 2022

mapped directly with Wikidata item

1 reference